World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
99
Citations
42461
World Ranking
8495
National Ranking
4385

Mark S. Litwin publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Mark S. Litwin sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 658 publications — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Mark S. Litwin D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Mark S. Litwin sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 99 D-Index — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Surgery
  • Cancer

Mark S. Litwin mainly investigates Prostate cancer, Internal medicine, Surgery, Prostatectomy and Quality of life. The various areas that he examines in his Prostate cancer study include Sexual function, Prostate, Radiation therapy and Gynecology. In his study, which falls under the umbrella issue of Internal medicine, Epidemiology of cancer is strongly linked to Oncology.

His study in Surgery is interdisciplinary in nature, drawing from both Kidney cancer, Renal cell carcinoma, Nephrectomy and Cystoscopy. His Prostatectomy research integrates issues from Logistic regression, Brachytherapy, Medicare beneficiary, Intensive care medicine and Prostate-specific antigen. His Quality of life study combines topics from a wide range of disciplines, such as Cross-sectional study, Physical therapy and Gerontology.

His most cited work include:

  • Quality of life and satisfaction with outcome among prostate-cancer survivors. (1747 citations)
  • Quality of life and satisfaction with outcome among prostate-cancer survivors. (1747 citations)
  • Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. (1098 citations)

What are the main themes of his work throughout his whole career to date?

The scientist’s investigation covers issues in Prostate cancer, Internal medicine, Oncology, Prostatectomy and Gynecology. His research integrates issues of Quality of life, Quality of life, Surgery and Prostate in his study of Prostate cancer. In his research on the topic of Quality of life, Prostatitis and Chronic prostatitis/chronic pelvic pain syndrome is strongly related with Physical therapy.

His Oncology research incorporates themes from Androgen deprivation therapy and Epidemiology of cancer. His Prostatectomy research is multidisciplinary, incorporating elements of Radiation therapy, Brachytherapy, General surgery and Urology. His Gynecology study incorporates themes from Health care quality and Family medicine.

He most often published in these fields:

  • Prostate cancer (50.84%)
  • Internal medicine (40.60%)
  • Oncology (20.13%)

What were the highlights of his more recent work (between 2014-2021)?

  • Prostate cancer (50.84%)
  • Internal medicine (40.60%)
  • Comorbidity (11.74%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Prostate cancer, Internal medicine, Comorbidity, Oncology and Cancer. Mark S. Litwin has researched Prostate cancer in several fields, including Gynecology, Quality of life, Cohort and Family medicine. His study in the field of Bladder cancer, Prospective cohort study and Survival analysis is also linked to topics like Variation.

His biological study spans a wide range of topics, including Survival rate, Surgery, Retrospective cohort study, Gerontology and Nephrectomy. His research in Surgery intersects with topics in Cystectomy, Prostatectomy, Disease and Patient experience. His Cancer research incorporates elements of Odds ratio, Psychiatry, Epidemiology and Hazard ratio.

Between 2014 and 2021, his most popular works were:

  • The Diagnosis and Treatment of Prostate Cancer: A Review. (339 citations)
  • Minimally important difference for the Expanded Prostate Cancer Index Composite Short Form. (123 citations)
  • Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008. (105 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Surgery

His main research concerns Internal medicine, Prostate cancer, Comorbidity, Cancer and Epidemiology. Mark S. Litwin has included themes like Perioperative and Oncology in his Internal medicine study. Mark S. Litwin interconnects Prospective cohort study, Gynecology, Quality of life and Cohort in the investigation of issues within Prostate cancer.

His Quality of life study integrates concerns from other disciplines, such as Urinary system and Brachytherapy. His studies deal with areas such as Stage, Surgery, Kidney cancer and Nephrectomy as well as Epidemiology. As a part of the same scientific family, Mark S. Litwin mostly works in the field of Surgery, focusing on Cystectomy and, on occasion, Disease.

Best Publications

  • How to Measure Survey Reliability and Validity

    Mark S. Litwin

  • Quality of life and satisfaction with outcome among prostate-cancer survivors.

    Martin G. Sanda;Rodney L. Dunn;Jeff Michalski;Howard M. Sandler

  • The National Institutes of Health chronic prostatitis symptom index: Development and validation of a new outcome measure

    Mark S. Litwin;Mary McNAUGHTON-COLLINS;Floyd J. Fowler;J. Curtis Nickel

  • Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer.

    John T Wei;Rodney L Dunn;Rodney L Dunn;Mark S Litwin;Howard M Sandler

  • Quality-of-life Outcomes in Men Treated for Localized Prostate Cancer

    Mark S. Litwin;Ron D. Hays;Arlene Fink;Patricia A. Ganz

  • The Diagnosis and Treatment of Prostate Cancer: A Review.

    Mark S. Litwin;Hung-Jui Tan

  • The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure.

    Mark S. Litwin;Ron D. Hays;Arlene Fink;Patricia A. Ganz

  • The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy.

    Matthew R. Cooperberg;David J. Pasta;Eric P. Elkin;Mark S. Litwin

  • Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer.

    Christopher S. Saigal;John L. Gore;Tracey L. Krupski;Janet Hanley

  • Comprehensive Comparison of Health-Related Quality of Life After Contemporary Therapies for Localized Prostate Cancer

    John T. Wei;Rodney L. Dunn;Howard M. Sandler;P. William McLaughlin

  • THE CONTEMPORARY MANAGEMENT OF PROSTATE CANCER IN THE UNITED STATES: LESSONS FROM THE CANCER OF THE PROSTATE STRATEGIC UROLOGIC RESEARCH ENDEAVOR (CAPSURE), A NATIONAL DISEASE REGISTRY

    Matthew R. Cooperberg;Jeanette M. Broering;Mark S. Litwin;Deborah P. Lubeck

  • DIFFERENCES IN UROLOGIST AND PATIENT ASSESSMENTS OF HEALTH RELATED QUALITY OF LIFE IN MEN WITH PROSTATE CANCER: RESULTS OF THE CAPSURE DATABASE

    Mark S. Litwin;Deborah P. Lubeck;James M. Henning;Peter R. Carroll

  • Leukocyte and Bacterial Counts Do Not Correlate With Severity of Symptoms in Men With Chronic Prostatitis: The National Institutes of Health Chronic Prostatitis Cohort Study

    Anthony J. Schaeffer;Jill S. Knauss;J. Richard Landis;Kathleen J. Propert

  • Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial.

    Richard B. Alexander;Kathleen J. Propert;Anthony J. Schaeffer;J. Richard Landis

  • Role of Surgeon Volume in Radical Prostatectomy Outcomes

    Jim C. Hu;Karen F. Gold;Chris L. Pashos;Shilpa S. Mehta

  • How To Assess and Interpret Survey Psychometrics

    Mark S. Litwin

  • Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy--part II: patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-up.

    Gary D Grossfeld;Mark S Litwin;J.Stuart Wolf;Hedvig Hricak

  • Urologic diseases in America Project: analytical methods and principal findings.

    Mark S. Litwin;Christopher S. Saigal;Elizabeth M. Yano;Chantal Avila

  • Quality of life at the end of life: trends in patients with metastatic prostate cancer

    Gil Y Melmed;Lorna Kwan;Kristen Reid;Mark S Litwin

  • The University of California, San Francisco Cancer of the Prostate Risk Assessment Score

    Matthew R. Cooperberg;David J. Pasta;Eric P. Elkin;Mark Litwin

Frequent Co-Authors

John T. Wei
John T. Wei University of Michigan–Ann Arbor
Peter R. Carroll
Peter R. Carroll University of California, San Francisco
Rodney L. Dunn
Rodney L. Dunn University of Michigan–Ann Arbor
Eric A. Klein
Eric A. Klein Cleveland Clinic
Deborah P. Lubeck
Deborah P. Lubeck University of California, San Francisco
J. Richard Landis
J. Richard Landis University of Pennsylvania
David F. Penson
David F. Penson Vanderbilt University Medical Center
Louis L. Pisters
Louis L. Pisters The University of Texas MD Anderson Cancer Center
Howard M. Sandler
Howard M. Sandler Cedars-Sinai Medical Center
J. Curtis Nickel
J. Curtis Nickel Queen's University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a future in healthcare doesn’t stop at studying Medicine in the USA. Many students consider online pathways in nursing to broaden their career options, especially when looking for flexibility and affordability. If budget is a concern, finding what is the cheapest online college for nursing? can help minimize debt while still achieving a respected credential.

For registered nurses aiming to further their education, there are cheapest rn to bsn online programs available to help you earn a bachelor’s degree efficiently. Those interested in advanced practice or academia might consider the cheapest phd nursing programs to access high-level roles without incurring massive costs.

If you don’t have a nursing background but wish to fast-track into the profession, exploring entry level msn programs online offers a direct route to a master’s degree and new career opportunities. These online nursing degrees open versatile pathways in healthcare, making it easier to launch or advance your career alongside your other commitments.

Best Scientists Citing Mark S. Litwin

Trending Scientists

Recently Published Articles